The influence of metronidazole (MET) resistance on the efficacy of two triple therapy regimens with ranitidine bismuth citrate (RBC) for H-pylori (Hp) infection

被引：0
|
作者：
Van der Wouden, EJ
Thijs, JC
van Zwet, AA
Kooy, A
Kleibeuker, JH
机构：
[1] Univ Groningen Hosp, Groningen, Netherlands
[2] Bethesda Hosp, Hoogeven, Netherlands
来源：
GUT | 1998年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A86 / A86
页数：1
相关论文
共 50 条
  • [21] Ranitidine bismuth citrate or omeprazole-based triple therapy for H-pylori eradication in H-pylori-infected nonulcer dyspepsia
    Chuang, CH
    Sheu, BS
    Yang, HB
    Wu, JJ
    Lin, XZ
    GUT, 2001, 49 : A93 - A93
  • [22] One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese
    Hung, WK
    Wong, WM
    Wong, GSW
    Yip, AWC
    Szeto, ML
    Lai, KC
    Hu, WHC
    Chan, CK
    Xia, HHX
    Yuen, MF
    Fung, FMY
    Tong, TSM
    Ho, VYK
    Lam, SK
    Wong, BCY
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (12) : 2067 - 2072
  • [23] Ranitidine bismuth citrate (RBC) and azithromycin with or without amoxicillin in the eradication of H-pylori in patients with peptic ulcer
    Katicic, M
    Duvnjak, M
    Vucelic, B
    Krizman, I
    Pavic-Sladoljev, D
    Culig, J
    Naletilic, D
    GUT, 1999, 45 : A115 - A115
  • [24] One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection:: A randomized, clinical trial
    van der Wouden, EJ
    Thijs, JC
    van Zwet, AA
    Kooy, A
    Kleibeuker, JH
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (08) : 1228 - 1231
  • [25] A randomized study comparing two ranitidine bismuth citrate (RBC) based regimens to cure Helicobacter pylori (Hp) infection in duodenal ulcer (DU) patients.
    Peyre, S
    Rizzi, R
    Gelci, L
    GUT, 2000, 47 : A110 - A110
  • [26] Triple therapy with ranitidine-bismuth citrate, clarithromycin and metronidazole to cure clarithromycin-resistant H. pylori
    Deprez, PH
    Burette, A
    De Prez, C
    Mana, F
    Avezani, V
    Glupczynski, Y
    GASTROENTEROLOGY, 2002, 122 (04) : A65 - A65
  • [27] Two open-label efficacy trials of ranitidine bismuth citrate (RBC) in combination with clarithromycin (C) and amoxicillin (A) or metronidazole (M) for Helicobacter pylori (HP) eradication.
    Crawford, JA
    Meyer, JM
    Herm-Barabasz, R
    Goldstein, JL
    GASTROENTEROLOGY, 1998, 114 (04) : A95 - A95
  • [28] Double therapy with ranitidine bismuth citrate (RBC) and clarithromycin during two weeks, has lower efficacy than triple therapy with RBC, clarithromycin and amoxicillin during one week in the eradication of H. pylori infection.
    Hergueta, P
    Rojas, M
    Romero, R
    Gomez, BJ
    Pellicer, FJ
    Herrerias, JM
    GASTROENTEROLOGY, 2000, 118 (04) : A1245 - A1245
  • [29] Comparison of omeprazole and ranitidine bismuth citrate(RBC)-based triple therapies for the eradication of H.pylori.
    Bardhan, KD
    Morton, D
    Willemse, PJ
    Basu, P
    Perry, MJ
    Rowland, A
    Morris, P
    Thompson, M
    Shaw, C
    Allen, H
    Roberts, PM
    GASTROENTEROLOGY, 2000, 118 (04) : A1214 - A1215
  • [30] Rescue therapy with ranitiefine bismuth citrate (RBC) after H-pylori treatment failure
    Gisbert, JP
    Fuentes, J
    Carpio, D
    Tito, L
    Guardiola, J
    Tomas, A
    Calvet, X
    GASTROENTEROLOGY, 2005, 128 (04) : A427 - A427
12345